Sammons, S. L., Leone, J. P., Sanglier, T., Sun, J., Lambert, P., Poppe, R., Monturus, E., Knott, A., Restuccia, E., Lin, N. U., Tolaney, S. M. (2025). Incidence and predictors of exceptional response (ExRes) in patients (pts) initiating first-line (1L) treatment for HER2-positive (HER2+) metastatic breast cancer (MBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13021